Tower Research Capital LLC (TRC) - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q2 2024$16,633
-13.2%
26,914
+261.0%
0.00%
Q1 2024$19,159
+21.0%
7,455
-3.9%
0.00%
Q4 2023$15,830
-73.6%
7,760
-77.7%
0.00%
-100.0%
Q3 2023$59,902
+406.4%
34,827
+474.1%
0.00%
Q2 2023$11,829
+65616.7%
6,066
-9.3%
0.00%
-100.0%
Q1 2023$18
-14.3%
6,689
+11.7%
0.00%0.0%
Q4 2022$21
-99.9%
5,990
-51.4%
0.00%0.0%
Q3 2022$31,000
+138.5%
12,325
+134.0%
0.00%
Q2 2022$13,000
-86.7%
5,266
-77.9%
0.00%
-100.0%
Q1 2022$98,000
+71.9%
23,855
+438.7%
0.00%0.0%
Q4 2021$57,000
-66.1%
4,428
-71.5%
0.00%
-75.0%
Q3 2021$168,000
+158.5%
15,524
+116.9%
0.00%
+100.0%
Q2 2021$65,000
-30.1%
7,157
-26.9%
0.00%0.0%
Q1 2021$93,000
+244.4%
9,787
+43.9%
0.00%
+100.0%
Q4 2020$27,000
-69.0%
6,800
-79.3%
0.00%0.0%
Q3 2020$87,000
+93.3%
32,841
+385.6%
0.00%
-50.0%
Q2 2020$45,000
+542.9%
6,763
+739.1%
0.00%
Q3 2019$7,0000.0%806
+56.5%
0.00%
Q1 2019$7,000
+600.0%
515
+560.3%
0.00%
Q4 2018$1,000780.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$41,970,0008.18%
Copernicus Capital Management, LLC 37,000$349,0005.64%
EcoR1 Capital, LLC 3,421,287$32,263,0001.43%
Palo Alto Investors LP 2,298,382$21,674,0001.24%
AlpInvest Partners B.V. 226,866$2,139,0001.06%
Stenahm Asset Managment Ltd 150,000$1,415,0001.00%
FRAZIER MANAGEMENT LLC 1,030,878$9,721,0000.78%
BVF INC/IL 1,861,239$17,551,0000.66%
Avidity Partners Management LP 2,122,064$20,011,0000.55%
Redmile Group, LLC 2,448,158$23,086,0000.32%
View complete list of GRITSTONE ONCOLOGY INC shareholders